Advanced search
Publication Cover
Journal of Chemotherapy Volume 13, 2001 - Issue sup1: Infection Prevention in the New Millennium: The Challenges Persist
Submit an article Journal homepage
51
Views
13
CrossRef citations to date
0
Altmetric
Invited Reviews

Trachoma: A Review

K.F. TabbaraDepartment of Ophthalmology, College of Medicine, King Saud University and The Eye Center, The Eye Foundation for Research in Ophthalmology, Riyadh, Saudi ArabiaCorrespondence[email protected]
Pages 18-22 | Published online: 27 Oct 2016

References

  • 1 Dawson CR, Jones BR, Tarizzo ML. Guide to trachoma control in programmes for the prevention of blindness. Geneva. World Health Organization; Albany, NY: WHO Publications Centre USA [distributor], 1981; 12–20.
  • 2 Tabbara KF, Ross-Degnan D. Blindness in Saudi Arabia. JAMA 1986; 255: 3378–3384.
  • 3 Tabbara KF. Chlamydia: trachoma and inclusion conjunctivitis. In: Tabbara KF, Hyndiuk RA eds. Infections of the Eye, 2nd edition. Boston: Little, Brown & Company, 1996: 433–451.
  • 4 Halberstaedter L, et al. Zur Aetiologie des Trachoms, Deutsch Med Wschr 1907; 33: 1285.
  • 5 Jones BR. Laboratory tests for chlamydial infections. Their role in epidemiological studies of trachoma and its control. Br J Ophthalmol 1974; 58: 438.
  • 6 Nichols RL. Studies on trachoma. Am J Trop Med Hyg 1966; 15: 639.
  • 7 Tabbara KF. Trachoma: an overview. In: Tabbara KF, ed. Special issue on Trachoma. Dordrecht. Kluwer Academic Publishers. Int Ophthalmol 1988; 12 (1): 5–8.
  • 8 Tabbara KF, Al-Omar OM. Trachoma in Saudi Arabia. Ophthal Epidemiol 1997; 4 (3): 127–140.
  • 9 Tabbara KF. Trachoma: Have we advanced in the last 20 years? Int Ophthalmol Clin 1990; 30 (1): 23–27.
  • 10 Dawson CR, Jones BR, et al. Blinding and nonblinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions. Bull WHO 1975; 52: 279.
  • 11 Taylor HR, Johnson SL, Schachter J, Prendergast RA. An animal model of trachoma: IV. The failure of local immunosuppression to reveal inapparent infection. Invest Ophthalmol Vis Sci 1983; 24: 647–650.
  • 12 Taylor HR, Johnson SL, Prendergast RA. Schachter J, Dawson CR, Silverstein AM. An animal model of trachoma. II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci 1982; 23: 507–515.
  • 13 Wang S, Grayston JT. Local and systemic response for trachoma eye infections in monkey. In: Trachoma and Related Disorders Caused by Chlamydial Agents. Nichols RL ed, 1971: 217–232.
  • 14 Whittum-Hudson JA, Taylor HR, Farazdaghi M, Prendergast RA. Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest Ophthalmol Vis Sci 1986; 27: 64–69.
  • 15 Tabbara KF, Bobb AA. Lacrimal system complications in trachoma. Ophthalmology 1980; 87(4): 298–301.
  • 16 Blodi BA, Byrne KA, Tabbara KF. Goblet cell population among patients with inactive trachoma. In: Tabbara KF, ed. Special issue on Trachoma. Dordrecht: Kluwer Academic Publishers. Int Ophthalmol 1988; 12(1): 41–45.
  • 17 Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomized controlled trial of single-dose azithromycin in treatment of trachoma Lancet 1993; 342: 453–456.
  • 18 Tabbara KF, Abu El-Asrar AM, Al-Omar OM, Chowdhury AH, Al-Faisal ZK. Single-doze azithromycin in the treatment of trachoma: a randomized, controlled study. Ophthalmology 1996; 103 (5): 842–846.
  • 19 Dawson CR, Schachter J, Sallam S, Sheta A, Rubinstein RA, Washton H. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis 1997; 24, 3: 363–368.
  • 20 Tabbara KF, Al-Kharashi SA, Al-Mansouri SM, et al. Ocular levels of azithromycin. Arch Ophthalmol 1998; 116: 1625–1628.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.